NEWS & EVENTS

Company News
Press Release

For Immediate Release
December 11, 2007

Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com

Contact: Risa Burgess
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com

Leerink Swann Named "Best of the Boutiques" by Institutional Investor for Seventh Consecutive Year

Boston, MA - December 20, 2007 - Leerink Swann, the leading healthcare investment banking firm, today announced that it secured top rankings in Institutional Investor's 2007 Best of Boutiques survey for the seventh consecutive year.

The company secured top honors in five out of six health care categories including: biotechnology, health care technology & distribution, medical supplies and devices, pharmaceuticals/major, and pharmaceuticals/specialty. For the 2007 All-America Research Team, Institutional Investor asks portfolio managers and buy-side analysts to name the best boutique or regional firms by sector.

"At Leerink Swann, we are exclusively focused on healthcare and on providing our clients with valuable insights from the most knowledgeable healthcare investment professionals. We have a highly specialized approach in providing the most critically relevant analytical information to our clients," said Jeff Leerink, Chairman and CEO, Leerink Swann. "For the seventh consecutive year, we are thrilled to be recognized by the buy-side community; it reaffirms the success and value of our unique knowledge platform that powers our business. We are grateful for the recognition and look forward to doing an even better job for our clients next year!"

About Leerink Swann & Company

Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences, and high-net-worth clients. For the past six years, Institutional Investor has named Leerink Swann Best of the Boutiques in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC.

"Best of the Boutiques" - Institutional Investor. Seventh consecutive year!